JOSÉ TOMÁS
RAMOS AMADOR
Catedrático de universidad
Chelsea and Westminster Hospital
Londres, Reino UnidoPublicaciones en colaboración con investigadores/as de Chelsea and Westminster Hospital (3)
2011
-
First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: An open-label, randomised phase 2/3 trial
The Lancet Infectious Diseases, Vol. 11, Núm. 4, pp. 273-283
2008
-
Plasma drug concentrations and virologic evaluations after stopping treatment with nonnucleoside reverse-transcriptase inhibitors in HIV type 1-infected children
Clinical Infectious Diseases, Vol. 46, Núm. 10, pp. 1601-1608
2002
-
Increased thymic output after initiation of antiretroviral therapy in human immunodeficiency virus type 1-infected children in the Paediatric European Network for Treatment of AIDS (PENTA) 5 trial
Journal of Infectious Diseases, Vol. 186, Núm. 3, pp. 312-320